TRIAMINIC EXPECTORANT DH SYRUP
TRIAMINIC EXPECTORANT DH SYRUP
Discontinued
DIN Number
01906615
Drug Class
Human
Market Date
Dec 31, 1993
Company
HC
novartis consumer health canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01906615
AIG Number0503200001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS
Product Specifications
Dosage FormSyrup
Route of AdministrationOral
AHFS Classification48:08.00
Health Canada Classification
ACTIVE INGREDIENTS (5)
GUAIFENESINActive
Strength: 100 MG / 5 ML
Monograph: GUAIFENESIN
HYDROCODONE BITARTRATEActive
Strength: 1.67 MG / 5 ML
Monograph: HYDROCODONE BITARTRATE
PHENIRAMINE MALEATEActive
Strength: 6.25 MG / 5 ML
Monograph: PHENIRAMINE MALEATE
PHENYLPROPANOLAMINE HYDROCHLORIDEActive
Strength: 12.5 MG / 5 ML
Monograph: PHENYLPROPANOLAMINE HYDROCHLORIDE
PYRILAMINE MALEATEActive
Strength: 6.25 MG / 5 ML
Monograph: PYRILAMINE MALEATE